Clinical RPh must submit collaborative agreement to

Clinical RPh must submit collaborative agreement to

• A. Board and BME
• B. Board only
• C. BME only
• D. Boarding organization

Answer: (A)

The key idea is that collaborative practice agreements between a clinical pharmacist and a physician are regulated by both the pharmacy authority and the medical authority. In Montana, the CPA must be filed with the Board of Pharmacy to address pharmacist scope of practice and supervision requirements, and with the Board of Medical Examiners to acknowledge the physician’s prescriptive authority and oversight under medical standards. Filing with both boards ensures that the agreement is recognized, enforceable, and aligned with both sets of professional regulations, safeguarding patient care. Submitting to only one body would leave regulatory oversight incomplete, and the notion of a “boarding organization” is not a regulatory entity.

The key idea is that collaborative practice agreements between a clinical pharmacist and a physician are regulated by both the pharmacy authority and the medical authority. In Montana, the CPA must be filed with the Board of Pharmacy to address pharmacist scope of practice and supervision requirements, and with the Board of Medical Examiners to acknowledge the physician’s prescriptive authority and oversight under medical standards. Filing with both boards ensures that the agreement is recognized, enforceable, and aligned with both sets of professional regulations, safeguarding patient care. Submitting to only one body would leave regulatory oversight incomplete, and the notion of a “boarding organization” is not a regulatory entity.